Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.36 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12350484 | 1.00 | HTR6 (0.36) | HTR6BIRC2CYP2C9TSHRCYP2C19 | |
| Hydrochloric Acid SCHEMBL2237196 | 0.98 | HTR6 (0.35) | HTR6BIRC2CYP2C9TSHRCYP2C19 | |
| SCHEMBL6582291 | 0.94 | HTR6 (0.39) | HTR6BIRC2DPP4MEN1KMT2A | |
| SCHEMBL6582294 | 0.94 | HTR6 (0.39) | HTR6BIRC2DPP4MEN1KMT2A | |
| SCHEMBL23139621 | 0.91 | BIRC2 (0.34) | HTR6BIRC2KMT2A | |
| SCHEMBL25698895 | 0.91 | BIRC2 (0.34) | HTR6BIRC2KMT2A | |
| Hydrochloric Acid SCHEMBL25337896 | 0.89 | HPGD (0.34) | BIRC2KMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL25337894 | 0.89 | HPGD (0.34) | BIRC2KMT2AALDH1A1 | |
| SCHEMBL17484304 | 0.85 | HPGD (0.33) | HTR6BIRC2KMT2A | |
| SCHEMBL15933081 | 0.83 | ALDH1A1 (0.42) | BIRC2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4041730-A1 | SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS | Bristol-Myers Squibb Company (US) | 2022-08-17 | — | — | EP | claimed |
| EP-4041730-A1 | SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS | Bristol-Myers Squibb Company (US) | 2022-08-17 | — | — | EP | disclosed |
| EP-2398780-B1 | CYCLOPROPYL AMIDE DERIVATIVES TARGETING THE HISTAMINE H3 RECEPTOR | ASTRAZENECA AB (SE) | 2013-04-17 | — | — | EP | disclosed |